EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020
This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 04 listopada 2024. Database contains 4917 unique substances/entries.
Filter the list
|
205-426-2
|
140-66-9
|
Skin Irrit. 2; Eye Dam. 1 |
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
|
257-907-1
|
52427-13-1
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
635-388-6
|
521947-27-3
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
635-389-1
|
186825-36-5
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
635-391-2
|
142731-63-3
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
635-696-0
|
186825-39-8
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
217-862-0
|
1987-50-4
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
-
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
284-325-5
|
84852-15-3
|
Repr. 2; Acute Tox. 4; Skin Corr. 1B |
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
|
-
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
-
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
1 - 2.5 moles ethoxylated
|
500-315-8
|
127087-87-0
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
|
1 - 2.5 moles ethoxylated
|
500-045-0
|
26027-38-3
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
|
202-679-0
|
98-54-4
|
Repr. 2; Skin Irrit. 2; Eye Dam. 1 |
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
|
621-345-9
|
2315-67-5
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
300-298-5
|
93925-00-9
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
234-284-4
|
11066-49-2
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
609-346-2
|
37205-87-1
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
246-672-0
|
25154-52-3
|
Repr. 2; Acute Tox. 4; Skin Corr. 1B |
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
|
1 - 2.5 moles ethoxylated
|
500-209-1
|
68412-54-4
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
|
500-024-6
|
9016-45-9
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
931-755-2
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
939-993-9
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
931-756-8
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
931-753-1
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||